NovaFlow Stent Biliary System

NovaFlow Stent Biliary System

Crafted from biocompatible materials, this advanced stent system ensures reliable biliary drainage by maintaining duct patency, effectively treating obstructions and supporting improved bile flow.

資訊

的 NovaFlow Stent Biliary System 是一個 進階, 微創 解決方案，旨在 restore 和 maintain bile duct patency in patients with benign 或 malignant biliary strictures. Engineered with 穩健 materials, precision deployment以及 (经过努力)获得 anchoring mechanisms, NovaFlow helps streamline biliary decompression under endoscopic 或 fluoroscopic guidance—promoting efficient care and 改進 patient outcomes.

Key Features & Design

High-Strength Stent Construction
  • Metal or Hybrid Materials (model-dependent): Offers consistent radial force to prop open the constricted duct while accommodating ductal peristalsis.
  • Biocompatible Coatings (if applicable): Minimizes friction or potential ingrowth, supporting better stent patency and easy retrieval when indicated.
  • Low-Profile Catheter: Facilitates navigation through the ampulla and ductal system, 減少 trauma to surrounding tissues.
  • Controlled Deployment: A user-friendly mechanism ensures progressive release of the stent, 限制 misplacement or sudden expansion.
  • Segmented Design (if applicable): Provides stable tissue contact points, decreasing migration risk in high-flow or dynamic duct segments.
  • Anti-Reflux / Anti-Migration Options (some models): May include flared ends or specialty coatings for long-term stent retention.
  • Fluoroscopic Guidance: Clear marker bands enhance visualization under X-ray, ensuring accurate stent placement across the stricture.
  • 即時回饋: Helps operators confirm final stent positioning and verify full expansion.
  • Metal or Hybrid Materials (model-dependent): Offers consistent radial force to prop open the constricted duct while accommodating ductal peristalsis.
  • Biocompatible Coatings (if applicable): Minimizes friction or potential ingrowth, supporting better stent patency and easy retrieval when indicated.
  • Low-Profile Catheter: Facilitates navigation through the ampulla and ductal system, 減少 trauma to surrounding tissues.
  • Controlled Deployment: A user-friendly mechanism ensures progressive release of the stent, 限制 misplacement or sudden expansion.
  • Segmented Design (if applicable): Provides stable tissue contact points, decreasing migration risk in high-flow or dynamic duct segments.
  • Anti-Reflux / Anti-Migration Options (some models): May include flared ends or specialty coatings for long-term stent retention.
  • Fluoroscopic Guidance: Clear marker bands enhance visualization under X-ray, ensuring accurate stent placement across the stricture.
  • 即時回饋: Helps operators confirm final stent positioning and verify full expansion.

Clinical Applications & Benefits

Benign & Malignant Biliary Strictures
  • Cholangiocarcinoma, pancreatic 或 ampullary neoplasms, sclerosing cholangitis或 post-surgical strictures: NovaFlow stents facilitate drainage and symptomatic relief of obstructive jaundice.
  • Palliation: Reduces pruritus, cholestasis, and infection risks in advanced disease.
  • Endoscopic Retrograde Cholangiopancreatography (ERCP): Stent introduction and release under endoscopic and/or fluoroscopic guidance, streamlining procedural flow.
  • Percutaneous Access (PTBD): If endoscopic approaches are unfeasible, the stent can be advanced through a percutaneous track (depending on system design).
  • Prompt Symptom Relief: Decompressing the biliary tract alleviates pain, pruritus, and hepatic dysfunction, restoring normal activities faster.
  • Reduced Procedure Frequency: Reliable stent patency and low migration rates diminish the need for multiple re-interventions.
  • Controlled Delivery: Minimizes ductal trauma or false passage creation, crucial in anatomically challenging or fibrotic ducts.
  • Stable Drainage: Intelligent design avoids kinking or stent collapse, preserving ongoing patency.
  • Cholangiocarcinoma, pancreatic 或 ampullary neoplasms, sclerosing cholangitis或 post-surgical strictures: NovaFlow stents facilitate drainage and symptomatic relief of obstructive jaundice.
  • Palliation: Reduces pruritus, cholestasis, and infection risks in advanced disease.
  • Endoscopic Retrograde Cholangiopancreatography (ERCP): Stent introduction and release under endoscopic and/or fluoroscopic guidance, streamlining procedural flow.
  • Percutaneous Access (PTBD): If endoscopic approaches are unfeasible, the stent can be advanced through a percutaneous track (depending on system design).
  • Prompt Symptom Relief: Decompressing the biliary tract alleviates pain, pruritus, and hepatic dysfunction, restoring normal activities faster.
  • Reduced Procedure Frequency: Reliable stent patency and low migration rates diminish the need for multiple re-interventions.
  • Controlled Delivery: Minimizes ductal trauma or false passage creation, crucial in anatomically challenging or fibrotic ducts.
  • Stable Drainage: Intelligent design avoids kinking or stent collapse, preserving ongoing patency.

相關商品